4BIO Capital
Venture capitalLondon · Pre-Seed–Series B · 27 people tracked
Also known as 4BIO PARTNERS LLP
Investment thesis
4BIO Capital is a specialist life sciences venture capital firm concentrating on advanced therapies. The firm targets companies developing treatments that address significant unmet medical and social needs, positioning its investments to deliver both scientific innovation and social impact.
Source: firm website, verified Aug 3, 2026.
Team · 27 people
from the firm's website & public directories
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Medical Devices ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathMarch Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.
BiotechMedical DevicesHouston, US
Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)
BoardThomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)
Principals & officers · per Companies House
what is this? ⓘDirector · British · since 2024
Director · British · since 2024
Dmitry Kuzmin — 25–50% of shares, 25–50% of voting rights, right to appoint and remove directors
Andrey Kozlov — 25–50% of shares, 25–50% of voting rights, right to appoint and remove directors
Frequently asked questions
- What stage does 4BIO Capital invest at?
- 4BIO Capital invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does 4BIO Capital focus on?
- 4BIO Capital focuses on Biotech, Healthtech, Medical Devices.
- Where is 4BIO Capital located?
- 4BIO Capital is headquartered in London, GB.
Images
Co-investors · 12
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
F-Prime Capital Partners is a venture capital firm whose team of scientists, engineers, physicians, operators, and investors supports companies in scaling and accelerating growth.
Northpond Ventures is a science- and technology-driven investment firm that backs breakthrough businesses aiming to have a significant impact on humanity.
venBio is a life sciences venture capital firm that partners with industry leaders to develop novel therapeutics and technologies addressing unmet medical needs.
Abingworth is a life science venture capital firm that backs early-stage biopharma and biotech companies, helping entrepreneurs translate scientific discoveries into new therapeutics.
BGF provides minority growth capital and support to entrepreneurial small and medium-sized businesses across the UK and Ireland, from university spinouts to established brands.
Pureos Bioventures is a venture capital firm that invests in private, innovative drug development companies, with a focus on next-generation biological drugs and drug formats to treat severe diseases.
Astellas Venture Management (AVM) is the wholly-owned corporate venture arm of Astellas, providing equity investments to private, early-stage biotechnology companies developing therapeutic programs and platform technologies for drug discovery.
Remiges Ventures is a venture capital firm focused on life sciences and drug discovery, backing biotech and therapeutics companies. It launched the RDiscovery Fund to incubate early-stage drug discovery projects.
82VS is a venture studio embedded within Alloy Therapeutics, a discovery platform and service provider, collaborating with academics, entrepreneurs, pharma, and VCs across company creation, drug discovery, and development.
Takeda Ventures, Inc. is the corporate venture capital arm of Takeda, making venture-based investments in therapeutic and platform-based companies to build the pharmaceutical company's pipeline and create strategic growth opportunities.
Firms observed investing alongside 4BIO Capital, from public investor directories. Shared companies are the overlap with 4BIO Capital's recorded portfolio.
Similar investors
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.
Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
BioGeneration Ventures is a venture capital firm that invests in early-stage biotech companies in Europe, with a focus on healthcare innovations.